Skip to search formSkip to main contentSkip to account menu

Dilevalol

Known as: Labetalol, (R,R)-Isomer, R,R Labetalol, R,R-Labetalol 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1991
1991
1991
1. This study investigated the influence of age on the pharmacokinetics, pharmacodynamics, general tolerability and concentration… 
Review
1990
Review
1990
Dilevalol, the RR-stereoisomer of labetalol, is a non-cardioselective beta-adrenoceptor antagonist with substantial partial beta… 
Highly Cited
1989
Highly Cited
1989
We compared dilevalol (an isomer of labetalol), 200-400 mg daily, against atenolol, 50-100 mg daily, in a double-blind, crossover… 
1988
1988
The bioavailability and pharmacokinetics of dilevalol following oral and intravenous administration were investigated in 12… 
1988
1988
Dilevalol combines a nonselective blocking action on beta-receptors with selective beta 2-agonist activity. In this double-blind… 
1988
1988
It is not surprising that there has been a search for compounds that combine two useful antihypertensive properties. The…